QIAGEN N.V. to release results for Q1 2022 and hold Webcast
April 20 2022 - 12:45PM
Business Wire
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA)
announced today that it plans to release results for the first
quarter of 2022 on Wednesday, April 27, at approximately 22:05
Frankfurt time / 21:05 London time / 16:05 New York time
Call date/time: Thursday, April 28, at 16:00 Frankfurt time /
15:00 London time / 10:00 New York time.
Hosts: Thierry Bernard, Chief Executive Officer, and
Roland Sackers, Chief Financial Officer.
Three options for joining the
call
Register for call back
connection
Click here:
Connect Me
Service available 15 minutes before call
start
Dial-in by phone
+1 929 477 0402 (U.S.)
+44 (0)330 165 3655 (UK)
+49 (0)69 2222 25574 (GER)
To avoid waiting time, please join the
event conference 5- 10 minutes prior to the start time.
Conference ID: 6602996
Access the audio webcast
Click here:
Access webcast
A conference call replay will be available by using the
following link:
https://globalmeet.webcasts.com/starthere.jsp?ei=1538117&tp_key=754eca7ed7
Contact: IR@qiagen.com
About QIAGEN
QIAGEN N.V., a Netherlands-based holding company, is the leading
global provider of Sample to Insight solutions that enable
customers to gain valuable molecular insights from samples
containing the building blocks of life. Our sample technologies
isolate and process DNA, RNA, and proteins from blood, tissue, and
other materials. Assay technologies make these biomolecules visible
and ready for analysis. Bioinformatics software and knowledge bases
interpret data to report relevant, actionable insights. Automation
solutions tie these together in seamless and cost-effective
workflows. QIAGEN provides solutions to more than 500,000 customers
around the world in Molecular Diagnostics (human healthcare),
Applied Testing (primarily forensics), Pharma (pharma and biotech
companies), and Academia (life sciences research). As of December
31, 2021, QIAGEN employed more than 6,000 people in over 35
locations worldwide. Further information can be found at
http://www.qiagen.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220420005924/en/
John Gilardi Vice President, Head of Corporate Communications
and Investor Relations +49 2103 29 11711 +1 240 686 2222 Email:
ir@qiagen.com
Phoebe Loh Senior Director Investor Relations +49 2103 29 11457
Email: ir@qiagen.com
Qiagen NV (NYSE:QGEN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Qiagen NV (NYSE:QGEN)
Historical Stock Chart
From Mar 2023 to Mar 2024